INVITRO ACTIVITY OF RIFAMPIN IN COMBINATION WITH OXACILLIN AGAINST STAPHYLOCOCCUS-AUREUS

被引:21
作者
TRACZEWSKI, MM
GOLDMANN, DA
MURPHY, P
机构
[1] CHILDRENS HOSP MED CTR,BACTERIOL LAB,BOSTON,MA 02115
[2] CHILDRENS HOSP MED CTR,DIV INFECT DIS,BOSTON,MA 02115
关键词
D O I
10.1128/AAC.23.4.571
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:571 / 576
页数:6
相关论文
共 26 条
[11]  
LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285
[12]   KILLING OF INTRALEUKOCYTIC STAPHYLOCOCCUS-AUREUS BY RIFAMPIN - IN-VITRO AND IN-VIVO STUDIES [J].
MANDELL, GL ;
VEST, TK .
JOURNAL OF INFECTIOUS DISEASES, 1972, 125 (05) :486-&
[13]   TREATMENT OF EXPERIMENTAL STAPHYLOCOCCAL INFECTIONS - EFFECT OF RIFAMPIN ALONE AND IN COMBINATION ON DEVELOPMENT OF RIFAMPIN RESISTANCE [J].
MANDELL, GL ;
MOORMAN, DR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (04) :658-662
[14]   EFFICACY OF RIFAMPIN AS ADJUNCTIVE THERAPY IN SELECTED CASES OF STAPHYLOCOCCAL ENDOCARDITIS [J].
MASSANARI, RM ;
DONTA, ST .
CHEST, 1978, 73 (03) :371-375
[15]   EXPERIMENTAL OSTEOMYELITIS .4. THERAPEUTIC TRIALS WITH RIFAMPIN ALONE AND IN COMBINATION WITH GENTAMICIN, SISOMICIN, AND CEPHALOTHIN [J].
NORDEN, CW .
JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (05) :493-499
[16]   SUSCEPTIBILITY OF STAPHYLOCOCCUS-AUREUS AND STAPHYLOCOCCUS-EPIDERMIDIS TO 65 ANTIBIOTICS [J].
SABATH, LD ;
GARNER, C ;
WILCOX, C ;
FINLAND, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 9 (06) :962-969
[17]  
SABATH LD, 1980, ANTIBIOTICS LABORATO, P451
[18]   ANTIMICROBIAL THERAPY OF EXPERIMENTAL ENDOCARDITIS CAUSED BY STAPHYLOCOCCUS-AUREUS [J].
SANDE, MA ;
JOHNSON, ML .
JOURNAL OF INFECTIOUS DISEASES, 1975, 131 (04) :367-375
[19]  
SENSI P., 1967, ANTIMICROB AGENTS CHEMOTHER, P699
[20]  
SIPPEL JE, 1974, AM REV RESPIR DIS, V109, P579